Track open bid opportunities, contracts, public meetings, and key contacts for Rush University.
Key metrics and characteristics
City
The city where this buyer is located.
Chicago
Enrollment
Total student enrollment.
2,769
IPEDS ID
Integrated Postsecondary Education Data System identifier.
148511
Employee FTE
Full-time equivalent employees.
1,338
Propensity to Spend
How likely this buyer is to spend on new technology based on operating budget trends.
AI Adoption Score
How likely this buyer is to adopt new AI technologies.
Startup Friendliness
How often this buyer champions startups and early adoption.
Latest Budget Year
Unlock to view
Operating Budget
Unlock to view
Includes fiscal year calendars, procurement complexity scores, and strategic insights.
Board meetings and strategic plans from Rush University
The committee reviewed several prior business items including amendments, renewals, and project closures. A new application investigating HIV infection in a humanized mouse model was discussed and granted provisional approval, contingent upon the completion of specific requirements including documentation updates, safety certification, and personnel training details. New business focused on updates regarding the NIH Draft Biosafety Policy for Research Involving Biohazards and the White House policy concerning high-risk life sciences research.
The Institutional Biosafety Committee reviewed several new applications for research involving recombinant DNA, viral vectors, and mouse models, resulting in provisional approvals contingent on meeting specific safety, training, and documentation requirements. The committee also acknowledged the review of prior business updates regarding various ongoing research applications. No new business, incident reports, or public comments were reported during the session.
The committee convened to discuss the findings of a recent medical journal article documenting the first case of AAV genomic integration and oncogenesis in a human patient. As a result, the committee mandated that all principal investigators of AAV vector studies update their Informed Consent Forms to include this risk of carcinogenesis within one month, and revise other study documents such as protocols and Investigator's Brochures within three months. The Institutional Review Board will also be notified of these requirements and the affected studies.
Extracted from official board minutes, strategic plans, and video transcripts.
Track Rush University meetings, strategic plans, and budget discussions before the public bid appears.
Early signals from meeting minutes and plans
Vendor mentions and competitor tracking
Decision timeline from discussion to RFP
Public-sector contacts connected to Rush University.
Quotable insights from buyer leadership
